Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 02, 2023

BUY
$31.15 - $33.39 $12,460 - $13,356
400 New
400 $13,000
Q3 2021

Oct 28, 2021

SELL
$17.35 - $22.5 $24,290 - $31,500
-1,400 Reduced 31.88%
2,992 $67,000
Q2 2021

Aug 12, 2021

SELL
$18.01 - $28.32 $61,143 - $96,146
-3,395 Reduced 43.6%
4,392 $97,000
Q1 2021

Apr 26, 2021

BUY
$19.76 - $29.89 $141,125 - $213,474
7,142 Added 1107.29%
7,787 $204,000
Q4 2020

Feb 02, 2021

BUY
$15.73 - $21.66 $10,145 - $13,970
645 New
645 $12,000
Q3 2020

Oct 14, 2020

SELL
$13.54 - $26.41 $98,544 - $192,211
-7,278 Closed
0 $0
Q2 2020

Jul 13, 2020

SELL
$7.84 - $23.29 $26,209 - $77,858
-3,343 Reduced 31.48%
7,278 $169,000
Q1 2020

Apr 29, 2020

BUY
$5.57 - $11.5 $31,041 - $64,089
5,573 Added 110.4%
10,621 $89,000
Q4 2019

Feb 05, 2020

BUY
$7.9 - $10.14 $38,038 - $48,824
4,815 Added 2066.52%
5,048 $49,000
Q3 2019

Oct 15, 2019

BUY
$9.17 - $12.01 $1,366 - $1,789
149 Added 177.38%
233 $2,000
Q2 2019

Jul 26, 2019

BUY
$10.88 - $17.6 $913 - $1,478
84 New
84 $0
Q1 2019

Apr 18, 2019

SELL
$15.51 - $17.61 $2,822 - $3,205
-182 Closed
0 $0
Q4 2018

Jan 16, 2019

SELL
$14.52 - $19.72 $3,978 - $5,403
-274 Reduced 60.09%
182 $3,000
Q3 2018

Oct 23, 2018

SELL
$14.85 - $16.35 $18,621 - $20,502
-1,254 Reduced 73.33%
456 $6,000
Q2 2018

Jul 30, 2018

SELL
$13.8 - $16.8 $5,188 - $6,316
-376 Reduced 18.02%
1,710 $27,000
Q1 2018

Apr 26, 2018

SELL
$13.8 - $16.2 $5,037 - $5,913
-365 Reduced 14.89%
2,086 $29,000
Q4 2017

Jan 10, 2018

BUY
$13.55 - $15.8 $28,956 - $33,764
2,137 Added 680.57%
2,451 $34,000
Q3 2017

Oct 25, 2017

BUY
$13.45 - $14.35 $4,223 - $4,505
314
314 $4,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.